Casodex: preclinical studies and controversies.

Suppr

超能文献

作者信息

Furr B J

机构信息

Vascular, Inflammatory and Musculoskeletal Research Department, Zeneca Pharmaceuticals, Cheshire, England.

出版信息

Ann N Y Acad Sci. 1995 Jun 12;761:79-96. doi: 10.1111/j.1749-6632.1995.tb31371.x.

DOI:10.1111/j.1749-6632.1995.tb31371.x

PMID:7625752

Abstract

摘要

相似文献

Casodex: preclinical studies and controversies.

Ann N Y Acad Sci. 1995 Jun 12;761:79-96. doi: 10.1111/j.1749-6632.1995.tb31371.x.

The development of Casodex (bicalutamide): preclinical studies.

Eur Urol. 1996;29 Suppl 2:83-95. doi: 10.1159/000473846.

Relative potency of bicalutamide (Casodex) and flutamide (Eulexin).

Urology. 1999 Jul;54(1):194-7.

"Casodex" (ICI 176,334)--a new, pure, peripherally-selective anti-androgen: preclinical studies.

Horm Res. 1989;32 Suppl 1:69-76. doi: 10.1159/000181315.

Antiproliferative activity of casodex (ICI 176.334) in hormone-dependent tumours.

J Cancer Res Clin Oncol. 1993;119(11):669-74. doi: 10.1007/BF01215986.

[Antiandrogen in prostate cancer].

Nihon Rinsho. 2002 Dec;60 Suppl 11:188-92.

[The use of Casodex (bicalutamide) in the treatment of disseminated prostatic cancer].

Urol Nefrol (Mosk). 1997 May-Jun(3):49-52.

'Casodex': defining the role of antiandrogens.

Cancer J Sci Am. 1997 Jul-Aug;3(4):204-8.

Bicalutamide ('Casodex') development: from theory to therapy.

Cancer J Sci Am. 1997 Jul-Aug;3(4):192-203.

Estimated potency of Casodex: a problematic design.

Urology. 1997 Aug;50(2):309-13.

引用本文的文献

Effect of small molecules modulating androgen receptor (SARMs) in human prostate cancer models.

PLoS One. 2013 May 8;8(5):e62657. doi: 10.1371/journal.pone.0062657. Print 2013.

Human prostate tumor growth in athymic mice: inhibition by androgens and stimulation by finasteride.

Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11802-7. doi: 10.1073/pnas.93.21.11802.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验